fashion -WSS

fashion

author：focus 2025-09-06 02:12:59 - browse：558

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Ending racial health disparities hinges on penalties, political will

WSS

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Awakening the world to the whoosh: A patient's crusade

'Screen and refer' systems are hurting patients

Skip the lead apron during X

Why Congress must ban federal programs from using QALYs

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

entertainment

fashion

knowledge

Apple is now the first public company to be valued at $3 trillion

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Continuity nursing helped my family in our darkest PICU moments

The wait for US passports is creating travel purgatory and snarling summer plans

Medical leaders decry Supreme Court decision on affirmative action

A letter from the executive editor: The 2023 STATUS List

Medicare proposal to cover medical devices draws a mixed reaction

AstraZeneca lung cancer study comes in below expectations

Duchenne breakthrough therapy leaves behind pioneering families

Hospitals struggle to profit from CAR

entertainment

The wait for US passports is creating travel purgatory and snarling summer plans

Judge rejects Trump's request to move Stormy Daniels hush

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

EF3 tornado rips through North Carolina amid extreme weather nationwide

What affirmative action's end means to a medical student

7 more heat

explore

leisure time

explore

entertainment